Skip to content

FLNA - FILANA THERAPEUTICS, INC. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchF

Filana Therapeutics, Inc.

FLNA · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

F

FLNAFilana Therapeutics, Inc.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $4.98
52-wk low: $0.85
Prev close: $2.82
Mkt cap: $46.7M
Fwd P/E: 151.5x
Beta: -0.69

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$7.5M

TS
Two Sigma
Q2 2026 13F
$2.0M
position
MW
Marshall Wace
Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 151.52
Market cap: $47M

Valuation

P/S2.54
P/B0.66

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: FLNA
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $46.68M
Beta: -0.69

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

2.5x

P/B

0.7x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-55.8%

$1.9M

position

DS

D.E. Shaw

Q2 2026 13F

$577K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for FLNA

No recent insider trade
No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

What the street expects next

-55.8%

ROA-5.6%

Growth

Beta-0.69